Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

163.15 +2.65 (+1.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why Brooklyn ImmunoTherapeutics Stock Crushed It in April
This clinical-stage biotech was one of April's brightest stars. 
Tags MRNA Market News BTX
From Motley Fool
4 Reasons to Hang On to Your Moderna Stock
A proposal to nullify intellectual property regarding COVID-19 vaccines seems unlikely to affect Moderna's bottom line. 
Tags NVAX Market News AZN
From Motley Fool
What's Going on With COVID Booster Shots?
Here are the latest updates for the key COVID-19 vaccine makers. 
Tags NVAX Market News MRNA
From Motley Fool
Dow, S&P 500 both log new records despite weak April jobs report
The Dow Jones Industrial Average and the S&P 500 index on Friday both finish at new records on the same day for the first time in about three weeks while the Nasdaq outperformed as technology stocks... 
Tags NKLA DJIA YMM21
From MarketWatch
Dow, S&P 500 both log new records despite weak April jobs report
The Dow Jones Industrial Average and the S&P 500 index on Friday both finish at new records on the same day for the first time in about three weeks while the Nasdaq outperformed as technology stocks... 
Tags ESM21 NKLA YMM21
From MarketWatch
COVID-19 Vaccine Patent Polarizes The World: What You Need To Know
The COVID-19 pandemic is continuing to rage unabated. Just as countries across the globe were coming online from a protracted lockdown, ... 
Tags JNJ General IBB
From Benzinga
Pfizer-BioNTech want full FDA approval for their vaccine — will a ‘yes’ improve vaccine hesitancy?
'This will be one less arrow in the concern quiver.' 
Tags MRNA JNJ BNTX
From MarketWatch
Europe divided on merits of patent waivers for COVID-19 vaccines
French President Emmanuel Macron rallied to the U.S. position and said he was “absolutely in favor” of patent waivers in the current context. Germany and Switzerland have voiced their opposition to the... 
Tags MRNA
From MarketWatch
EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots
European Medical Agency (EMA) isreviewing reportsof a rare nerve-degenerating disorder in people who ... 
Tags Benzinga MRNA News
From Benzinga
Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca’s
People under the age of 40 in the U.K. will be offered an alternative to the AstraZeneca COVID-19 vaccine, where possible, due to an "extremely small risk" from rare blood clots. 
Tags AZN BNTX UK:AZN
From MarketWatch
'Fast Money Halftime Report' Picks For May 7
On CNBC's "Fast Money Halftime Report," Bryn Talkington recommended a long position in iShares US Small Cap Value Factor ... 
Tags Stephen Weiss Bryn Talkington SVAL
From Benzinga
The U.S. prepares to begin giving COVID-19 shots to 12- to 15-year-olds as Pfizer’s vaccine nears expanded authorization
Now that the U.S. is getting close to authorizing the first COVID-19 vaccine for younger teens, it will pave the way for immunizations to begin to reach a broader group of Americans at a time when the... 
Tags BNTX PFE MRNA
From MarketWatch
Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca’s
People under the age of 40 in the U.K. will be offered an alternative to the AstraZeneca COVID-19 vaccine, where possible, due to an "extremely small risk" from rare blood clots. 
Tags PFE UK:AZN AZN
From MarketWatch
Europe divided on merits of patent waivers for COVID-19 vaccines
French President Emmanuel Macron rallied to the U.S. position and said he was “absolutely in favor” of patent waivers in the current context. Germany and Switzerland have voiced their opposition to the... 
Tags MRNA
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when different age groups could become eligible for shots.
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12- to 15-year-olds within the week. If that occurs, it will be the first shot authorized... 
Tags BNTX PFE NVAX
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when to expect a shot for different age groups
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12 to 15-year-olds within the week. If that occurs, it will be the first shot authorized... 
Tags PFE BNTX JNJ
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when to expect a shot for different age groups
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12 to 15-year-olds within the week. If that occurs, it will be the first shot authorized... 
Tags BNTX PFE NVAX
From MarketWatch
Dow Jones Hits High As Metals, Miners, Fertilizers Thrive, But Growth Stocks Slump; Jobs Report Stunningly Weak
The Dow and S&P 500 hit highs but growth stocks struggled, despite a Friday bounce on a weak jobs report. Miners, metals and fertilizer stocks thrived. 
From Investor's Business Daily
What 14 Analyst Ratings Have To Say About Moderna
Analysts have provided the following ratings for Moderna (NASDAQ:MRNA) within the last quarter: Last 30 Days 1 Month Ago 2 ... 
Tags Benzinga MRNA Analyst Ratings
From Benzinga
COVID-19 was never going to have a tidy Hollywood ending
The coronavirus pandemic will end was it began --- unpredictably. 
Tags PFE ZM AZN
From MarketWatch
Ocugen Stock Has a Big Pullback Coming, and That Will Be Your Chance
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OGCN Stock had a nice run in recent weeks but faces risks of a sharp pullback that could lead to paper losses for speculators. The post... 
Tags BNTX Hot Stocks Market News
From InvestorPlace
Ocugen Stock Is a Risky Proposition Despite Its High Valuation
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OCGN stock soared on a deal to commercialize Bharat Biotech’s Covaxin in the U.S., but the rollout comes with a lot of challenges. The... 
Tags OCGN MRNA Hot Stocks
From InvestorPlace
What's Going On With Moderna Stock Today?
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 3.18% at $165.60in Friday's pre-market session, recovering some of the ... 
Tags MRNA Trading Ideas Benzinga
From Benzinga
Europe divided on merits of patent waivers for COVID-19 vaccines
French President Emmanuel Macron rallied to the U.S. position and said he was “absolutely in favor” of patent waivers in the current context. Germany and Switzerland have voiced their opposition to the... 
Tags MRNA
From MarketWatch
Is herd immunity a realistic concept? Fauci calls it ‘elusive’ and ‘mystical’
Of all the moving goal posts in the COVID-19 pandemic, herd immunity may be the most difficult to pin down — and it may even be the wrong metric to track. 
Tags MRNA PFE
From MarketWatch
Moderna’s first-ever profit and billion-dollar quarter is dampened by COVID-19 vaccine patent proposal
It's been a complicated day for Moderna Inc. as the company reported its first-ever profit and its first-ever billion dollars in sales amidst an unprecedented move by the Biden administration to... 
Tags MRNA SPX BNTX
From MarketWatch
Dow aims for longest win streak since March ahead of April jobs report
The Dow Jones Industrial Average is set to add to its record ride Friday, as investors brace for a report on conditions in the U.S. labor market as the economy recovers from COVID pandemic. 
Tags YM00 COMP ESM21
From MarketWatch
Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca in U.K.: reports
People under the age of 40 in the U.K. will be offered an alternative to the AstraZeneca COVID-19 vaccine as a precautionary measure, following concerns of rare blood clots linked to the shot, several... 
Tags PFE UK:AZN AZN
From MarketWatch
Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market?
The biotech faces some big challenges. 
Tags JNJ MRNA OCGN
From Motley Fool
Here Are the Best Healthcare Stocks That Robinhood Investors Love
There are some well-known and not-so-well-known names on the list. 
Tags BNGO TNXP MRNA
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.